A CAGR of 8.5% is expected of the global sinus dilation devices market, due to the growing demand during the forecast period. It is anticipated to be appraised at US$ 5.1 Bn by 2032, up from US$ 2.26 Bn in 2022.
| Attributes | Details |
|---|---|
| Sinus Dilation Devices Market Size (2022) | US$ 2.26 Billion |
| Sinus Dilation Devices Market Size (2032) | US$ 5.1 Billion |
| Sinus Dilation Devices Market CAGR | 8.5% |
Sinuplasty systems supplied by key manufacturers allow skilled Otolaryngologists to dilate clogged sinus Ostia and airways in sinusitis patients using endoscopic procedures. The system is built on a flexible, over-the-wire design that allows a clinician to negotiate complex sinus anatomy while confirming device position with the sinus illumination system focused light.
Furthermore, sinuplasty technology adds to the progress of sinus surgery by providing a surgeon with extra instruments for endoscopic surgery. Additionally, sinuplasty products are catheter-based devices that help Otolaryngologists achieve their surgical aims of clearing clogged sinuses, restoring normal sinus drainage and function, and conserving normal architecture and mucosal tissue. During balloon sinus surgery, the adoption of sinus dilation device systems is rising as they feature rigid balloon sinus seekers that have been pre-calibrated for surgical navigation using navigation systems.
End users can utilize these technologies provided by major suppliers to find and move tissue, bone, or cartilage along sinus drainage routes. Furthermore, balloon sinus dilation offers doctors easy, targeted balloon sinus surgery devices with built-in electromagnetic (EM) surgical navigation technology.
In contrast, a eustachian tube dilation balloon is a manually controlled balloon catheter device that expands and dilates the eustachian tube canal. The demand for sinus dilation devices is rising, especially for ENT navigation systems, since they have been successfully launched by key firms. They were developed and manufactured by the company's ENT branch of its surgical technology business. Key clinicians' surgical technologies create products and procedural solutions for surgical applications such as ear, nose, and throat; cranial and functional neurosurgery; spinal and orthopedics; and general surgical cancer.
The majority of medical device firms are focused on creating innovative medicines to enhance people's sinus health. Their sinus dilation devices are intended to alleviate sinusitis symptoms in a straightforward two-step interventional procedure. The sales of sinus dilation devices are likely to surge as it allows for progressive dilatation of the maxillary sinus Ostia, which is intended to improve patient comfort during the treatment in an office environment under local anesthetic.
The sinus dilation system, as opposed to balloon dilation devices that employ quick, high-pressure inflation, is a tiny, low-pressure, self-expanding insert meant to softly and gradually dilate the maxillary Ostia. The sinus dilation devices market growth is expected to be driven as they are developed using the concerned company's unique osmotic technology, which uses the body's natural mucosal fluids to enlarge the insert before removal. Patients are pleasantly transported to the waiting room in an office environment between device insertion and removal. These factors are estimated to be the growth of the sinus dilation devices market growth.
Extracorporeal septoplasty is considered medically required for the first treatment of a highly deviated nasal septum that cannot be properly corrected using an intranasal technique for members who match the septoplasty criteria given above. For all other purposes (e.g., allergic rhinitis), they consider septoplasty experimental and exploratory since its efficacy in comparison to other kinds has not been shown.
Most major corporations offer a diverse sinus surgery portfolio tailored to address the expanding demands of sinus surgeons. From their sinus dilation devices, a new breakthrough that aids patients with sinus difficulties, to their gel knit, detachable nasal dressing, which is meant to minimize post-op adhesions, key players are continuously innovating products. These factors are anticipated to drive product demand and expand the global sinus dilation device market size in the forecast period.
Sinuses are the hollow sacks in the head which are responsible for secretion of mucus and provide resonance to the voice. The mucus secreted by the sinuses prevents the nasal cavity from drying and works by trapping the foreign particles that enter the nasal passage and reaching to lungs.
The sinuses have an opening that allows the mucus to drain from and flow into nasal passage, however in some cases the sinus opening gets blocked, and the mucus remains logged into the sinus causing headache, congestion, and inflammation of the sinus, it also increases the risk of causing an infection, this condition is termed as sinusitis.
Depending on the duration of the symptoms, sinusitis is classified into three types, acute, sub - acute and chronic. The treatment of sinusitis depends on the longevity of the infection. To relieve the patient from the symptoms, treatment options like drugs, surgery, and physical therapy are available.
In the chronic case where the sinuses remain blocked for a longer time, the doctors opt for surgery. The rhinoplasty surgery is a procedure in which surgeons dilate the sinuses to relieve the mucus and decrease pressure in the sinuses.
The growing incidence of sinusitis is expected to boost demand for sinus dilation devices worldwide. According to the Center of Disease Control and Prevention (CDC), in the U.S. nearly 12% of the population in the age group of 18 years and above suffer from sinusitis.
The increasing rate of chronic sinusitis is expected to provide high growth opportunities for the sinus dilation devices manufacturers.
Moreover, the development of new devices and technologies like balloon sinus dilation systems more physicians are expected to opt for these devices for treating sinusitis, as these devices are more effective and less invasive the risk to patients is minimal, which in turn is expected to create high demand from the patients as well as physicians.
Several companies like Medtronic and Acclarent, Inc. are focused on the development of new products for sinus dilation which in turn is expected to increase adoption of new technology-based products owing to increasing availability of these products in the market.
However, prescription drugs like antibiotics and decongestants, being the primary treatment method for treatment of sinusitis the adoption of devices for sinus dilation is comparatively low, which in turn is expected to reduce revenue growth of the sinus dilation devices market.
Globally the sinus dilation devices market is expected to witness robust growth over the forecast period owing to new product development, products which are less invasive and easy to use in physician office settings are expected to gain traction over the forecast period.
Moreover increasing distribution network of manufacturers and growing awareness among the physicians is expected to create high growth opportunities for the stakeholders of sinus dilation devices market.
Regionally, sinus dilation devices market is segmented into seven key regions, North America, Latin America, Western Europe, Eastern Europe, APEJ (Asia-Pacific excluding Japan), Japan and the Middle East and Africa (MEA)
North America is expected to dominate the sinus dilation devices market over the forecast period. According to the U.S. statistics of CDC in 2013, 29 million people in the U.S. were affected with chronic sinusitis and is ranked as one of the ten costliest physical health conditions.
The demand for rapid treatment offered by new sinus dilation systems is expected to create increase over the forecast period. Western Europe is expected to follow next after North America owing to increasing awareness of sinus dilation devices in this region.
Increasing incidence of chronic sinusitis and large patient pool in APEJ region is expected to boost demand for sinus dilation devices in this regions. Japan is expected to follow next regarding revenue growth owing to technological developments and an introduction of new products from the local players.
Latin America and MEA regions are also expected to witness significant growth in sinus dilation devices market over the forecast period.
Some key players in the sinus dilation devices market include Acclarent, Inc., Medtronic, Entellus Medical, Inc., SinuSys Corporation., Smith & Nephew plc. Aetna, Inc., KARL STORZ GmbH & Co. KG, Olympus Corporation and others
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The sinus dilation devices market is segmented into three key segments, by product type, by end user and by region
The market is likely to register a CAGR of 8.5% through 2032.
The market is currently valued at US$ 2.26 Bn in 2022.
The market is likely to grow to a valuation of US$ 5.1 Bn by 2032.
North America is likely to be a leading market during the forecast period.
Explore Similar Insights
Sinus Dilation Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
